Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016233 |
---|---|
Receipt number | R000018837 |
Scientific Title | A Phase II/III, randomized, double-blind, placebo-controlled study and open active-treatment extension study to assess the efficacy and safety of the branch chain amino acids (BCAAs) in polymyositis and dDermatomyositis. |
Date of disclosure of the study information | 2015/01/20 |
Last modified on | 2020/07/08 11:43:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/16 11:58:02 | ||
2 | Update | 2015/01/26 15:52:39 | Public title Acronym |
|
3 | Update | 2015/01/26 15:53:52 | Narrative objectives1 |
|
4 | Update | 2015/01/26 15:54:51 | Key inclusion criteria |
|
5 | Update | 2015/03/12 12:18:51 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
6 | Update | 2015/03/12 12:19:46 | Recruitment status |
|
7 | Update | 2016/11/04 15:20:36 | UMIN ID1 |
|
8 | Update | 2016/11/04 15:37:12 | Concealment Target sample size |
|
9 | Update | 2016/11/04 15:42:31 | Last name of contact person Last name of contact person Name of primary person or sponsor Institute Organization Organization Organization Category of Funding Organization |
|
10 | Update | 2016/11/04 15:46:07 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2017/05/01 12:08:59 | Recruitment status |
|
12 | Update | 2020/07/08 11:43:41 | Recruitment status Date of IRB |